Inhaled Ciclesonide for Patients With Asthma or Chronic Obstructive Pulmonary Disease and COVID-19-Reply
JAMA Intern Med
.
2022 May 1;182(5):572.
doi: 10.1001/jamainternmed.2022.0210.
Authors
Brian M Clemency
1
,
David J Koster
2
,
Michael S Blaiss
3
Affiliations
1
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York.
2
Instat Clinical Research, Chatham, New Jersey.
3
Medical College of Georgia at Augusta University, Augusta.
PMID:
35311914
DOI:
10.1001/jamainternmed.2022.0210
No abstract available
Publication types
Comment
MeSH terms
Administration, Inhalation
Asthma* / drug therapy
COVID-19*
Humans
Pregnenediones* / therapeutic use
Pulmonary Disease, Chronic Obstructive* / drug therapy
Substances
Pregnenediones
ciclesonide